This is a summary of the European public assessment report (EPAR) for Pregabalin Accord. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Pregabalin Accord. For practical information about using Pregabalin Accord, patients should read the package leaflet or contact their doctor or pharmacist.
Therapeutic Indication
### Therapeutic indication Epilepsy - Pregabalin Accord is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation. Generalised Anxiety Disorder - Pregabalin Accord is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults.
Therapeutic Area (MeSH)
ATC Code
N03AX16
ATC Item
xn 03 ax 16
Pharmacotherapeutic Group
Antiepileptics
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| pregabalin | N/A | 普瑞巴林 |
EMA Name
Pregabalin Accord
Medicine Name
Pregabalin Accord
Aliases
N/ANo risk management plan link.
